TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Alfimed AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
14,054
|
12,811
|
14,512 |
| Financial expenses |
580
|
4
|
1 |
| Earnings before taxes |
2,305
|
3,231
|
5,407 |
| Total assets |
6,480
|
6,874
|
8,262 |
| Current assets |
6,343
|
6,716
|
8,158 |
| Current liabilities |
4,398
|
4,292
|
6,148 |
| Equity capital |
2,083
|
2,582
|
2,115 |
| - share capital |
66
|
71
|
75 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.1%
|
37.6%
|
25.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
16.4%
|
25.2%
|
37.3% |
| Return on assets (ROA) |
44.5%
|
47.1%
|
65.5% |
| Current ratio |
144.2%
|
156.5%
|
132.7% |
| Return on equity (ROE) |
110.7%
|
125.1%
|
255.7% |
| Change turnover |
2,030
|
-939
|
4,272 |
| Change turnover % |
17%
|
-7%
|
42% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.